Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data

(2015) P S Hall et al.   BRITISH JOURNAL OF CANCER

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

(2014) E L Turner et al.   BRITISH JOURNAL OF CANCER

In-Hospital Resource Use and Medical Costs in the Last Year of Life by Mode of Death (from the HF-ACTION Randomized Controlled Trial)

(2012) Shelby D. Reed et al.   AMERICAN JOURNAL OF CARDIOLOGY

SPOILT FOR CHOICE: IMPLICATIONS OF USING ALTERNATIVE METHODS OF COSTING HOSPITAL EPISODE STATISTICS

(2011) Claudia Geue et al.   HEALTH ECONOMICS

Administrative database research infrequently used validated diagnostic or procedural codes

(2011) Carl van Walraven et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

End-of-Life and Formal and Informal Care Use of Community-Dwelling Older Adults with Different Levels of Physical Disability

(2011) YongJoo Rhee et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

What is the value of collecting detailed costing data in clinical trials?

(2011) Helen Dakin et al.   Trials

Methods for the Collection of Resource Use Data within Clinical Trials: A Systematic Review of Studies Funded by the UK Health Technology Assessment Program

(2010) Colin H. Ridyard et al.   VALUE IN HEALTH

Healthcare costs associated with prostate cancer: estimates from a population-based study

(2009) Murray D. Krahn et al.   BJU INTERNATIONAL

Assessment of transparency of cost estimates in economic evaluations of patient safety programmes

(2009) Haruhisa Fukuda et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE